@2019 Ningbo Linstant Polymer Materials Co.,Ltd 

浙ICP备15004068号    Powered by 300.cn

  • Linstant
  • Linstant
  • Linstant

PRODUCT

It’s ensured that the processes from the purchases of raw material, the production, the inspection, to the packing processes are traceable.

It’s ensured that the processes from the purchases of raw material, the production, the inspection, to the packing processes are traceable.

With the support of senior self-R & D team and profound-cooperation

Scientific SCM methods, integrating and optimizing resources, 

The nearly 30 years’ manufacturing experience and outstanding product quality are 

With the mature sales and after-sales team and partners all

over the world, our professional technical

ABOUT US 

Ningbo Linstant Polymer Materials Co., Ltd., a professional manufacturer of polymer accessories for medical device, combining research, design and production as a whole part, provides 'one to one' customized solutions

for minimally invasive medical device companies.
Based on customers’requirements, the company applies the medical grades PP, PE, PA,TPU, PC, PEBAX, PEEK and other materials to produce: s

FDA Expands Indication for Melody Transcatheter Valve for Failed Surgical Valves
saibao

FDA Expands Indication for Melody Transcatheter Valve for Failed Surgical Valves

FDA Expands Indication for Melody Transcatheter Valve for Failed Surgical Valves Number of visits:50 Date:2017-4-11 March 14, 2017 — The United States Food and Drug Administration (FDA) has expanded use of the Medtronic Melody Transcatheter Pulmonary Valve (TPV) for implantation in patients whose surgical bioprosthetic pulmonary heart valves have failed.
ACC 2017 Late-Breaking Trials
saibao

ACC 2017 Late-Breaking Trials

Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presented at ACC.17 March 17-19

NEWS CENTER 

It’s ensured that the processes from the purchases of raw material, the production, the inspection, to the packing processes are traceable.